Céline Imhof

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Jan‐Stephan Sanders, Fréderike J. Bemelman, A. Lianne Messchendorp et al. · Transplantation · 2021 · 196 citations · Full text

Medicine, Immunology, Nephrology +15

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

Jan‐Stephan Sanders, Fréderike J. Bemelman, A. Lianne Messchendorp et al. · PubMed · 2022 · 122 citations · Full text

Medicine, Immunology, Nephrology +11

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Marcia M. L. Kho, A. Lianne Messchendorp, Sophie C. Frölke et al. · The Lancet Infectious Diseases · 2022 · 74 citations · Full text

Veterinary Medicine, Immunology, Nephrology +16

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Jan‐Stephan Sanders, A. Lianne Messchendorp, Rory D. de Vries et al. · Clinical Infectious Diseases · 2022 · 55 citations · Full text

Medicine, Immunology, Nephrology +15

Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study

Pim Bouwmans, A. Lianne Messchendorp, Jan‐Stephan Sanders et al. · BMC Nephrology · 2022 · 30 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14